Study provides further insight into the molecular control of apoptosis

Researchers at Yale School of Medicine have gained deeper understanding of two members of a family of proteins called caspases that play a key role in promoting apoptosis, a process in which the cell responds to external signals by essentially committing suicide.

Published in Science, the study focused on caspase 3 and caspase 7. By breeding mice deficient in both of these proteins, the team was able to closely study their role in apoptosis, which is important to a wide range of normal physiologic processes, such as embryonic development and proper management of the immune system. Apoptosis also occurs in disease states, such as stroke, heart attacks and degenerative diseases such as Alzheimer's. Insufficient apoptosis can lead to autoimmune diseases and cancer.

In this study, mice that lacked caspases 3 and 7 had defects in cardiac development and died within the first day of life. "Using fibroblasts from these mice, we were able to determine that a lack of these two proteins renders individual cells highly resistant to dying," said first author on the study Saquib A. Lakhani, associate research scientist in the Department of Pediatrics and the Section of Immunobiology at Yale School of Medicine.

Lakhani and co-authors were further able to show that caspases 3 and 7 play a fundamental role in controlling mitochondrial events of apoptosis, including dissipation of energy production.

"Although mitochondria are primarily known as the energy generators of cells, they control apoptosis by releasing a variety of pro-apoptotic factors," said Lakhani. "These results provide further insight into the molecular control of apoptosis and are relevant to the wide variety of health and disease processes that rely on apoptosis."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New study unveils why glioblastoma becomes resistant to treatment